期刊
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
卷 109, 期 6, 页码 367-372出版社
OXFORD UNIV PRESS
DOI: 10.1093/qjmed/hcv181
关键词
-
资金
- National Cancer Institute [CA149438, CA166327]
- American Cancer Society [RSG 13-139-01-CNE]
Glucose and glutamine metabolismin cancer cells are markedly elevated relative to non-transformed normal cells. This metabolic reprogramming enables the production of adenosine triphosphate and the anabolic precursors needed for survival, growth and motility. The recent observations that mutant oncogenic proteins and the loss of tumor suppressors activate key metabolic enzymes suggest that selective inhibition of these enzymes may yield effective cancer therapeutics with acceptable toxicities. In support of this concept, pre-clinical studies of small molecule antagonists of several metabolic enzymes in tumor-bearing mice have demonstrated reasonable therapeutic indices. We will review the rationale for targeting metabolic enzymes as a strategy to treat cancer and will detail the results of several recent clinical trials of metabolic inhibitors in advanced cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据